These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29998127)

  • 21. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Characteristics and Contemporary Management of Patients With Cardiomyopathies in Japan　- Report From a National Registry of Clinical Personal Records.
    Enzan N; Matsushima S; Ide T; Kaku H; Tohyama T; Funakoshi K; Higo T; Tsutsui H;
    Circ Rep; 2021 Feb; 3(3):142-152. PubMed ID: 33738347
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of clinical and MRI features between dilated cardiomyopathy and left ventricular noncompaction].
    Yu JC; Zhao SH; Jiang SL; Wang LM; Wang ZF; Lu MJ; Ling J; Zhang Y; Yan CW; Liu Q; Cheng HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 May; 38(5):392-7. PubMed ID: 20654095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiomyopathies due to defective energy metabolism: morphological and functional features].
    Giordano C; D'Amati G
    Pathologica; 2005 Dec; 97(6):361-8. PubMed ID: 16619977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium Ions in Inherited Cardiomyopathies.
    Deftereos S; Papoutsidakis N; Giannopoulos G; Angelidis C; Raisakis K; Bouras G; Davlouros P; Panagopoulou V; Goudevenos J; Cleman MW; Lekakis J
    Med Chem; 2016; 12(2):139-50. PubMed ID: 26411603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Restrictive and Hypertrophic Cardiomyopathies After LVAD: An INTERMACS Analysis.
    Patel SR; Saeed O; Naftel D; Myers S; Kirklin J; Jorde UP; Goldstein DJ
    J Card Fail; 2017 Dec; 23(12):859-867. PubMed ID: 28970073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
    Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
    Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights provided by myofibril mechanics in inherited cardiomyopathies.
    Lin YH; Yap J; Ramachandra CJA; Hausenloy DJ
    Cond Med; 2019 Oct; 2(5):213-224. PubMed ID: 32133438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies.
    Vio R; Angelini A; Basso C; Cipriani A; Zorzi A; Melacini P; Thiene G; Rampazzo A; Corrado D; Calore C
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34062949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.
    Yadav S; Sitbon YH; Kazmierczak K; Szczesna-Cordary D
    Pflugers Arch; 2019 May; 471(5):683-699. PubMed ID: 30706179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obscurin variants and inherited cardiomyopathies.
    Marston S
    Biophys Rev; 2017 Jun; 9(3):239-243. PubMed ID: 28510120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies.
    Charron P; Elliott PM; Gimeno JR; Caforio ALP; Kaski JP; Tavazzi L; Tendera M; Maupain C; Laroche C; Rubis P; Jurcut R; Calò L; Heliö TM; Sinagra G; Zdravkovic M; Kavoliuniene A; Felix SB; Grzybowski J; Losi MA; Asselbergs FW; García-Pinilla JM; Salazar-Mendiguchia J; Mizia-Stec K; Maggioni AP;
    Eur Heart J; 2018 May; 39(20):1784-1793. PubMed ID: 29378019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects.
    Monserrat L; Hermida-Prieto M; Fernandez X; Rodríguez I; Dumont C; Cazón L; Cuesta MG; Gonzalez-Juanatey C; Peteiro J; Alvarez N; Penas-Lado M; Castro-Beiras A
    Eur Heart J; 2007 Aug; 28(16):1953-61. PubMed ID: 17611253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?
    Willott RH; Gomes AV; Chang AN; Parvatiyar MS; Pinto JR; Potter JD
    J Mol Cell Cardiol; 2010 May; 48(5):882-92. PubMed ID: 19914256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
    Li M; Chen X; Chen L; Chen K; Zhou J; Song J
    J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.
    Akdis D; Medeiros-Domingo A; Gaertner-Rommel A; Kast JI; Enseleit F; Bode P; Klingel K; Kandolf R; Renois F; Andreoletti L; Akdis CA; Milting H; Lüscher TF; Brunckhorst C; Saguner AM; Duru F
    Heart Rhythm; 2016 Mar; 13(3):731-41. PubMed ID: 26569459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyopathy.
    Roberts JD; Veinot JP; Rutberg J; Gollob MH
    Cardiovasc Pathol; 2010; 19(5):316-20. PubMed ID: 19632136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy].
    Sjöberg G; Kostareva A; Sejersen T
    Lakartidningen; 2005 Mar 14-20; 102(11):845-7, 850-3. PubMed ID: 15835520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.